SEC Filing Summary: Ra Medical Systems, Inc. (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Ra Medical Systems, Inc. on March 14, 2019. The filing serves as a current report to announce the company's financial results for the fourth quarter and full year ended December 31, 2018. The registrant is incorporated in Delaware and maintains its principal executive offices in Carlsbad, California.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts as a notification that these results were announced via a press release (attached as Exhibit 99.1) and discussed in a conference call held on the date of the report. No financial tables or specific metric data are embedded within the body of this 8-K text.
Material Changes
The filing does not detail specific material changes versus prior periods. It references the attached press release for the full discussion of operational and financial performance for the fourth quarter and full year 2018.
Guidance, Outlook, and Risks
The text indicates that management held a conference call to discuss results but does not contain specific guidance, outlook statements, risk factors, or contingencies within this document. The information furnished in Item 2.02 and Exhibit 99.1 is explicitly stated as not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 14, 2019) for actual revenue, net income, and cash flow figures.
- Verify the company's name: The filing is for Ra Medical Systems, Inc., not "Catheter Precision, Inc." as noted in the request metadata.
- Confirm the reporting period covers the fourth quarter and full year ended December 31, 2018.
- Note that the financial data in this specific 8-K text is not legally "filed" under Section 18 liability standards.